((3AR,4R,6aR)-2,2-dimethyl-6-oxotetrahydrofuro[3,4-d][1,3]dioxol-4-yl)methyl 4-methylbenzenesulfonate

Catalog No. :
ACHNUT589
CAS No. :
109715-12-0
Molecular Formula :
C15H18O7S
Molecular Weight :
342.37

IUPAC Name:((3aR,4R,6aR)-2,2-dimethyl-6-oxotetrahydrofuro[3,4-d][1,3]dioxol-4-yl)methyl 4-methylbenzenesulfonate

((3AR,4R,6aR)-2,2-dimethyl-6-oxotetrahydrofuro[3,4-d][1,3]dioxol-4-yl)methyl 4-methylbenzenesulfonate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name((3AR,4R,6aR)-2,2-dimethyl-6-oxotetrahydrofuro[3,4-d][1,3]dioxol-4-yl)methyl 4-methylbenzenesulfonate
IUPAC Name((3aR,4R,6aR)-2,2-dimethyl-6-oxotetrahydrofuro[3,4-d][1,3]dioxol-4-yl)methyl 4-methylbenzenesulfonate
MDL No.MFCD13194927
Molecular FormulaC15H18O7S
Molecular Weight342.37
SMILESO=S(C1=CC=C(C)C=C1)(OC[C@H]([C@@]2([H])OC(C)(C)O[C@]23[H])OC3=O)=O
InChI KeyLPINTYGCWKERKL-JHJVBQTASA-N
Synonym5-(p-Toluenesulfonate)-2,3-O-isopropylidene-2-C-methyl-D-ribonic-gamma-lactone;5-(p-Toluenesulfonate)-2,3-O-isopropylidene-2-C-methyl-D-ribonic-γ-lactone;D-Ribonic acid, 2-C-methyl-2,3-O-(1-methylethylidene)-, γ-lactone, 5-(4-methylbenzenesulfonate)
CAS No.109715-12-0

Synthetic Route by SureRoute

1. ACHNUT589 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACHNUT589 route product structure diagram
    ACHNUT589109715-12-0
Inquiry

2. ACHNUT589 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACBOTS812 route compound structure diagram
    ACBOTS81230725-00-9 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACHNUT589 route product structure diagram
    ACHNUT589109715-12-0
Inquiry

Comments (0)